Latest Nitriles Stories
CORAL SPRINGS, Florida, March 17, 2015 /PRNewswire/ -- The latest medical projects aimed to prevent illnesses, particularly ones related to aging and lifestyle, including
- Treatment for Major Depressive Disorder (MDD) in Adults- DUBLIN, March 16, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced the U.S.
DALLAS, January 30, 2015 /PRNewswire/ -- The report "Pyrethroids Market [http://www.marketsandmarkets.com/Market-Reports/pyrethroids-pesticide-market-170901303.html ] by
DUBLIN, October 17, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/dmzsmx/global_and ) has announced the addition of the "Global
A single dose of antidepressant is enough to produce dramatic changes in the functional architecture of the human brain.
Low viscosity MB250NT is a newly developed, single component ethyl cyanoacrylate that cures exceptionally fast at room temperature.
Takeda and Lundbeck Announce Results at American Society of Clinical Psychopharmacology Annual Meeting HOLLYWOOD, Fla., June 17, 2014 /PRNewswire/ -- Takeda Pharmaceuticals Company Limited
Eight abstracts will highlight enzalutamide studies in prostate and breast cancers NORTHBROOK, Ill. and SAN FRANCISCO, May 14, 2014 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S.
Federal judge to rule on expert witness testimony over allegations that children suffered birth defects due to mothers’ use of Zoloft, Prozac, Celexa, Luvox, Paxil, Lexapro or Viibryd during
DUBLIN, Ireland, April 17, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/hlj6ph/acrylonitrile) has announced the addition of the